First Header Logo Second Header Logo

Connection

Michael Nader to Humans

This is a "connection" page, showing publications Michael Nader has written about Humans.
Connection Strength

0.287
  1. Nader MA. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Prog Brain Res. 2016; 224:3-24.
    View in: PubMed
    Score: 0.028
  2. Nader MA, Banks ML. Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging. Neuropharmacology. 2014 Jan; 76 Pt B:510-7.
    View in: PubMed
    Score: 0.024
  3. Gould RW, Duke AN, Nader MA. PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations. Neuropharmacology. 2014 Sep; 84:138-51.
    View in: PubMed
    Score: 0.023
  4. Nader MA, Czoty PW, Nader SH, Morgan D. Nonhuman primate models of social behavior and cocaine abuse. Psychopharmacology (Berl). 2012 Nov; 224(1):57-67.
    View in: PubMed
    Score: 0.023
  5. Gould RW, Porrino LJ, Nader MA. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation. Curr Top Behav Neurosci. 2012; 11:25-44.
    View in: PubMed
    Score: 0.022
  6. Nader M, Reindl D, Eichinger R, Beheshti M, Langsteger W. Improved quality control of [18F]fluoromethylcholine. Nucl Med Biol. 2011 Nov; 38(8):1143-8.
    View in: PubMed
    Score: 0.021
  7. Nader MA, Czoty PW. Brain imaging in nonhuman primates: insights into drug addiction. ILAR J. 2008; 49(1):89-102.
    View in: PubMed
    Score: 0.016
  8. Martelle JL, Nader MA. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther. 2008; 14(3):248-62.
    View in: PubMed
    Score: 0.016
  9. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci. 2006 Aug; 9(8):1050-6.
    View in: PubMed
    Score: 0.015
  10. Nader MA, Czoty PW. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry. 2005 Aug; 162(8):1473-82.
    View in: PubMed
    Score: 0.014
  11. Newman AH, Grundt P, Nader MA. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J Med Chem. 2005 Jun 02; 48(11):3663-79.
    View in: PubMed
    Score: 0.014
  12. Weber M, Kurek C, Barbato F, Eiber M, Maurer T, Nader M, Hadaschik B, Grünwald V, Herrmann K, Wetter A, Fendler WP. PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study. J Nucl Med. 2021 01; 62(1):88-91.
    View in: PubMed
    Score: 0.010
  13. Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Proc Natl Acad Sci U S A. 2016 09 13; 113(37):E5511-8.
    View in: PubMed
    Score: 0.007
  14. Heilig M, Epstein DH, Nader MA, Shaham Y. Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci. 2016 09; 17(9):592-9.
    View in: PubMed
    Score: 0.007
  15. Maldjian JA, Shively CA, Nader MA, Friedman DP, Whitlow CT. Multi-Atlas Library for Eliminating Normalization Failures in Non-Human Primates. Neuroinformatics. 2016 04; 14(2):183-90.
    View in: PubMed
    Score: 0.007
  16. Keck TM, John WS, Czoty PW, Nader MA, Newman AH. Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis. J Med Chem. 2015 Jul 23; 58(14):5361-80.
    View in: PubMed
    Score: 0.007
  17. Phillips KA, Bales KL, Capitanio JP, Conley A, Czoty PW, 't Hart BA, Hopkins WD, Hu SL, Miller LA, Nader MA, Nathanielsz PW, Rogers J, Shively CA, Voytko ML. Why primate models matter. Am J Primatol. 2014 Sep; 76(9):801-27.
    View in: PubMed
    Score: 0.006
  18. Balster RL, Nader MA, Freeman KB. Obituary: William L. Woolverton. Psychopharmacology (Berl). 2013 Sep; 229(2):379-81.
    View in: PubMed
    Score: 0.006
  19. Beheshti M, Haim S, Zakavi R, Steinmair M, Waldenberger P, Kunit T, Nader M, Langsteger W, Loidl W. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics. J Nucl Med. 2013 Jun; 54(6):833-40.
    View in: PubMed
    Score: 0.006
  20. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012 Oct 01; 84(7):882-90.
    View in: PubMed
    Score: 0.006
  21. Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Hammer J, Loidl W, Pirich C, Fogelman I, Langsteger W. The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT. Mol Imaging Biol. 2010 Jan-Feb; 12(1):98-107.
    View in: PubMed
    Score: 0.005
  22. Porrino LJ, Smith HR, Nader MA, Beveridge TJ. The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1593-600.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.